Qingchao Qiu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qingchao Qiu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alfred L GeorgeJr
Department of Pharmacology, Vanderbilt University, Nashville, TN
2 shared publications - Yajun Yi
Department of Medicine, Vanderbilt University, Nashville, TN 37232-0275, USA
2 shared publications - Bojana Jovanovic
Department of Cancer Biology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 2220 Pierce Avenue, 698 Preston Research Building, Nashville, TN 37232, USA
1 shared publication - Brian D. Lehmann
Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
1 shared publication - Christine Q. Simmons
Department of Medicine, Vanderbilt University, Nashville, TN 37232-0275, USA
1 shared publication - David J. DeGraff
Vanderbilt University, Nashville, USA
1 shared publication
Latest Publications
- Open Access
- 20 July 2013
- Published by Wiley in Molecular Oncology
- Vol. 7 (6) , 1019-1030
SPARCL1 suppresses metastasis in prostate cancer
Purpose: Metastasis, the main cause of death from cancer, remains poorly understood at the molecular level.Experimental design: Based on a pattern of reduced expression in human prostate cancer tissues and tumor cell lines, a candidate suppressor gene (SPARCL1) was identified. We used in vitro approaches to determine whether overexpression of SPARCL1 affects cell growth, migration, and invasiveness. We then employed xenograft mouse models to analyze the impact of SPARCL1 on prostate cancer cell growth and metastasis in vivo.Results: SPARCL1 expression did not inhibit tumor cell proliferation in vitro. By contrast, SPARCL1 did suppress tumor cell migration and invasiveness in vitro and tumor metastatic growth in vivo, conferring improved survival in xenograft mouse models.Conclusions: We present the first in vivo data suggesting that SPARCL1 suppresses metastasis of prostate cancer.
- 20 July 2013
- Published by Wiley in Molecular Oncology
- Vol. 7 (6) , 1019-1030
Open AccessSPARCL1 suppresses metastasis in prostate cancer
Purpose: Metastasis, the main cause of death from cancer, remains poorly understood at the molecular level.Experimental design: Based on a pattern of reduced expression in human prostate cancer tissues and tumor cell lines, a candidate suppressor gene (SPARCL1) was identified. We used in vitro approaches to determine whether overexpression of SPARCL1 affects cell growth, migration, and invasiveness. We then employed xenograft mouse models to analyze the impact of SPARCL1 on prostate cancer cell growth and metastasis in vivo.Results: SPARCL1 expression did not inhibit tumor cell proliferation in vitro. By contrast, SPARCL1 did suppress tumor cell migration and invasiveness in vitro and tumor metastatic growth in vivo, conferring improved survival in xenograft mouse models.Conclusions: We present the first in vivo data suggesting that SPARCL1 suppresses metastasis of prostate cancer.
- Open Access
- 14 December 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 420
Web-based interrogation of gene expression signatures using EXALT
Background: Widespread use of high-throughput techniques such as microarrays to monitor gene expression levels has resulted in an explosive growth of data sets in public domains. Integration and exploration of these complex and heterogeneous data have become a major challenge. Results: The EXALT (EX pression signature A naL ysis T ool) online program enables meta-analysis of gene expression profiles derived from publically accessible sources. Searches can be executed online against two large databases currently containing more than 28,000 gene expression signatures derived from GEO (Gene Expression Omnibus) and published expression profiles of human cancer. Comparisons among gene expression signatures can be performed with homology analysis and co-expression analysis. Results can be visualized instantly in a plot or a heat map. Three typical use cases are illustrated. Conclusions: The EXALT online program is uniquely suited for discovering relationships among transcriptional profiles and searching gene expression patterns derived from diverse physiological and pathological settings. The EXALT online program is freely available for non-commercial users from http://seq.mc.vanderbilt.edu/exalt/.
- 14 December 2009
- Published by Springer Nature in BMC Bioinformatics
- Vol. 10 (1) , 420
Open AccessWeb-based interrogation of gene expression signatures using EXALT
Background: Widespread use of high-throughput techniques such as microarrays to monitor gene expression levels has resulted in an explosive growth of data sets in public domains. Integration and exploration of these complex and heterogeneous data have become a major challenge. Results: The EXALT (EX pression signature A naL ysis T ool) online program enables meta-analysis of gene expression profiles derived from publically accessible sources. Searches can be executed online against two large databases currently containing more than 28,000 gene expression signatures derived from GEO (Gene Expression Omnibus) and published expression profiles of human cancer. Comparisons among gene expression signatures can be performed with homology analysis and co-expression analysis. Results can be visualized instantly in a plot or a heat map. Three typical use cases are illustrated. Conclusions: The EXALT online program is uniquely suited for discovering relationships among transcriptional profiles and searching gene expression patterns derived from diverse physiological and pathological settings. The EXALT online program is freely available for non-commercial users from http://seq.mc.vanderbilt.edu/exalt/.